“With between 15 and 20% of cases in high income countries being caused by urinary tract infection, and with resistance to first-line treatment among the most common urinary pathogens running as high as 50% in some regions, any product which improves diagnostic accuracy will not only improve outcomes for individual patients but is also likely to help us counter the threat of AMR,” says Dr Ron Daniels BEM, Founder and joint CEO of The Sepsis Trust.
“Sepsis is a condition responsible for 1 in 5 deaths worldwide. Sepsis is the final common pathway to death from most infectious diseases. It is intrinsically interlinked with antimicrobial resistance (AMR), and lack of diagnostic accuracy hampers efforts not only to treat sepsis but also to deliver responsible antimicrobial stewardship.”
Evidence based Peezy Midstream is one of these devices. Designed by Dr Vincent Forte, NHS GP for over 20 years, Forensic Physician and medical author to improve women’s urological health it enjoyed ten years of rigorous R&D before entering the market in 2015, generating significant excellent evidence around reduced retesting, reduced prescribing and transformed patient outcoes. #notjustaproduct!